{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:05:28Z","timestamp":1782187528725,"version":"3.54.5"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:p>Impulse control disorders (ICD) in Parkinson's disease (PD) have attracted increasing interest. They are characterized by the inability to control the impulse to perform an act that can be detrimental to them or to others. Although dopamine agonists (DA), as a group, have been associated with impulse control disorders (ICD), piribedil has rarely been reported to cause them. Method Case reports of six parkinsonian patients on piribedil presenting pathological gambling (PG). Results All of the patients presented ICD associated with piribedil use. Two of them received this medication as first treatment and four of them who had developed ICDs secondary to other DA that reappeared with piribedil. Conclusion Despite piribedil is commercially available in only a few countries, it should be considered in the differential diagnosis of PG in patients with PD.<\/jats:p>","DOI":"10.1590\/0004-282x20140212","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T20:52:14Z","timestamp":1424897534000},"page":"115-118","source":"Crossref","is-referenced-by-count":11,"title":["Piribedil and Pathological Gambling in six Parkinsonian patients"],"prefix":"10.1590","volume":"73","author":[{"given":"Federico E.","family":"Micheli","sequence":"first","affiliation":[{"name":"Universidad de Buenos Aires,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Giugni","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micke E. De Arco","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela S.","family":"Calvo","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela B.","family":"Raina","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"1-2","key":"ref1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2011.05.044","article-title":"Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study","volume":"310","author":"\u00c1vila A","year":"2011","journal-title":"J Neurol Sci"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease","volume":"66","author":"Voon V","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon V","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease","volume":"67","author":"Pontone G","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub D","year":"2006","journal-title":"Arch Neurol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub D","year":"2010","journal-title":"Arch Neurol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina JA","year":"2000","journal-title":"Mov Disord"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series","volume":"22","author":"Gallagher DA","year":"2007","journal-title":"Mov Disord"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of pathological gambling in patients with Parkinson's disease","volume":"21","author":"Avanzi M","year":"2006","journal-title":"Mov Disord"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0b013e3181c4ae2e","article-title":"Impulse control disorder and piribedil: report of 5 cases","volume":"33","author":"Tschopp L","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease","volume":"64","author":"Voon V","year":"2007","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S1353-8020(09)70847-8","article-title":"Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management","volume":"15","author":"Ceravolo R","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","article-title":"The relationship between impulsivity and impulse control disorders in Parkinson's disease","volume":"23","author":"Isaias IU","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.22472","article-title":"Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease","volume":"24","author":"Santangelo G","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/WNF.0b013e31823d78ab","article-title":"Dose-dependent impulse control disorders in piribedil overdose","volume":"35","author":"Giugni JC","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/603631","article-title":"Dopamine agonists and pathologic behaviors","volume":"2012","author":"Kelley BJ","year":"2012","journal-title":"Parkinson's disease"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/CPJ.0b013e318278be9b","article-title":"Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease","volume":"2","author":"Weiss HD","year":"2012","journal-title":"Neurol Clin Practice"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1017\/S1092852900013778","article-title":"Impulse-control disorders in Parkinson's disease","volume":"13","author":"Ferrara JM","year":"2008","journal-title":"CNS Spectr"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00415-011-6270-z","article-title":"Zoophilia and impulse control disorder in a patient with Parkinson disease","volume":"259","author":"Raina G","year":"2012","journal-title":"J Neurology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas A","year":"2010","journal-title":"Ann Neurol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub D","year":"2010","journal-title":"Ann Neurol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1353-8020(03)00096-8","article-title":"Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience","volume":"10","author":"Evidente VG","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/WNF.0b013e31821f0d8b","article-title":"Piribedil-induced sleep attacks in patients without Parkinson disease: a case series","volume":"34","author":"Gouraud A","year":"2011","journal-title":"Clin neuropharmacol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1472-8206.2003.00122.x","article-title":"Piribedil-induced sleep attacks in Parkinson's disease","volume":"17","author":"Tan EK","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/mds.21122","article-title":"Early piribedil monotherapy of Parkinson's disease: a planned seven-month report of the REGAIN study","volume":"21","author":"Rascol O","year":"2006","journal-title":"Mov Disord"},{"issue":"8","key":"ref26","first-page":"500","article-title":"Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting","volume":"101","author":"Hastak SM","year":"2003","journal-title":"J Indian Med Assoc"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v73n2\/0004-282X-anp-73-02-115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,28]],"date-time":"2017-05-28T00:15:10Z","timestamp":1495930510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2015000200115&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0004-282X2015000200115"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20140212","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}